NCT03044795 2024-05-03
REPAIR
University Medical Center Groningen
Phase 2 Withdrawn
Clinical Trials
3 trialsNCT02723864 2022-02-08
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01853306 2017-11-21
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
AbbVie
Phase 1 Completed